DE10256080A1 - Tiotropiumhaltige Arzneimittelkombination für die Inhalation - Google Patents

Tiotropiumhaltige Arzneimittelkombination für die Inhalation Download PDF

Info

Publication number
DE10256080A1
DE10256080A1 DE10256080A DE10256080A DE10256080A1 DE 10256080 A1 DE10256080 A1 DE 10256080A1 DE 10256080 A DE10256080 A DE 10256080A DE 10256080 A DE10256080 A DE 10256080A DE 10256080 A1 DE10256080 A1 DE 10256080A1
Authority
DE
Germany
Prior art keywords
inhalation
medicament according
hydrogen
medicament
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10256080A
Other languages
German (de)
English (en)
Inventor
Ingo Konetzki
Christopher J. Montague Meade
Michel Pairet
Michael P. Pieper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to DE10256080A priority Critical patent/DE10256080A1/de
Priority to CA2507656A priority patent/CA2507656C/en
Priority to EP03779979A priority patent/EP1581224B1/de
Priority to US10/717,868 priority patent/US7250426B2/en
Priority to ES03779979T priority patent/ES2298597T3/es
Priority to JP2004556154A priority patent/JP4850415B2/ja
Priority to DK03779979T priority patent/DK1581224T3/da
Priority to AT03779979T priority patent/ATE384531T1/de
Priority to AU2003288107A priority patent/AU2003288107A1/en
Priority to PCT/EP2003/012913 priority patent/WO2004050093A1/de
Priority to DE50309096T priority patent/DE50309096D1/de
Publication of DE10256080A1 publication Critical patent/DE10256080A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE10256080A 2002-11-29 2002-11-29 Tiotropiumhaltige Arzneimittelkombination für die Inhalation Withdrawn DE10256080A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE10256080A DE10256080A1 (de) 2002-11-29 2002-11-29 Tiotropiumhaltige Arzneimittelkombination für die Inhalation
CA2507656A CA2507656C (en) 2002-11-29 2003-11-19 Tiotropium-containing medicament combinations used for inhaling
EP03779979A EP1581224B1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination fuer die inhalation
US10/717,868 US7250426B2 (en) 2002-11-29 2003-11-19 Tiotropium-containing pharmaceutical combination for inhalation
ES03779979T ES2298597T3 (es) 2002-11-29 2003-11-19 Combinacion de medicamentos que contienen tiotropio para la inhalacion.
JP2004556154A JP4850415B2 (ja) 2002-11-29 2003-11-19 吸入用チオトロピウム含有医薬品組成物
DK03779979T DK1581224T3 (da) 2002-11-29 2003-11-19 Tiotropiumholdig lægemiddelsammensætning til inhalation
AT03779979T ATE384531T1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination fuer die inhalation
AU2003288107A AU2003288107A1 (en) 2002-11-29 2003-11-19 Tiotropium-containing medicament combinations used for inhaling
PCT/EP2003/012913 WO2004050093A1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination für die inhalation
DE50309096T DE50309096D1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination fuer die inhalation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10256080A DE10256080A1 (de) 2002-11-29 2002-11-29 Tiotropiumhaltige Arzneimittelkombination für die Inhalation

Publications (1)

Publication Number Publication Date
DE10256080A1 true DE10256080A1 (de) 2004-06-17

Family

ID=32318866

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10256080A Withdrawn DE10256080A1 (de) 2002-11-29 2002-11-29 Tiotropiumhaltige Arzneimittelkombination für die Inhalation
DE50309096T Expired - Lifetime DE50309096D1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination fuer die inhalation

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50309096T Expired - Lifetime DE50309096D1 (de) 2002-11-29 2003-11-19 Tiotropiumhaltige arzneimittelkombination fuer die inhalation

Country Status (9)

Country Link
EP (1) EP1581224B1 (ja)
JP (1) JP4850415B2 (ja)
AT (1) ATE384531T1 (ja)
AU (1) AU2003288107A1 (ja)
CA (1) CA2507656C (ja)
DE (2) DE10256080A1 (ja)
DK (1) DK1581224T3 (ja)
ES (1) ES2298597T3 (ja)
WO (1) WO2004050093A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
NZ605920A (en) * 2010-07-16 2015-01-30 Cipla Ltd Pharmaceutical compositions comprising r (+) budesonide and one or more bronchodilators

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
EP1581224B1 (de) 2008-01-23
ES2298597T3 (es) 2008-05-16
AU2003288107A1 (en) 2004-06-23
WO2004050093A1 (de) 2004-06-17
DE50309096D1 (de) 2008-03-13
JP4850415B2 (ja) 2012-01-11
ATE384531T1 (de) 2008-02-15
JP2006509776A (ja) 2006-03-23
EP1581224A1 (de) 2005-10-05
CA2507656A1 (en) 2004-06-17
CA2507656C (en) 2011-07-12
DK1581224T3 (da) 2008-03-25

Similar Documents

Publication Publication Date Title
EP1335728B1 (de) Arzneimittelkompositionen auf der basis von tiotropiumsalzen und salzen des salmeterols
EP2105143B1 (de) Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Ciclesoniden
EP1497289B1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
EP1408967A2 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika; corticosteroiden und betamimetika zur behandlung von entzündlichen und/oder obstruktiven atemwegserkrankungen
EP1385519A2 (de) Tiotropiumsalzen zur behandlung von inflammatorischen erkrankungen
DE10104367A1 (de) Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
EP1530471A1 (de) Inhalative arzneimittel enthaltend ein neues anticholinergikum in kombination mit corticosteroiden und betamimetika
WO2002036106A2 (de) Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
WO2006056527A1 (de) Inhalative arzneimittel enthaltend ein anticholinergikum, salmeterol und ein steroid aus der gruppe ciclesonide oder mometasonfuroat
EP1496902A1 (de) Arzneimittel enthaltend steroide und ein neues anticholinergikum
DE10104370A1 (de) Arzneimittelkompositionen mit geringeren Nebenwirkungen
EP1827432A1 (de) Inhalative arzneimittel enthaltend ein neues anticholinergikum, formoterol und ein steroid
DE10111058A1 (de) Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und NK¶1¶-Rezeptor-Antagonisten
EP1581224B1 (de) Tiotropiumhaltige arzneimittelkombination fuer die inhalation
EP1341538A2 (de) Neue arzneimittelkompositionen aus tiotropiumsalzen und antihistaminika zur therapie von atemswegserkrankungen
WO2002074034A2 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und endothelinantagonisten
EP1586574A1 (de) Arzneimittel enthaltend Betamimetika und ein neues Anticholinergikum
EP1521580A1 (de) Neue arzneimittelkompositionen auf der basis neuer anticholinergika und nk1-rezeptor-antagonisten
EP1345626A2 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und dopamin-agonisten
DE102004038886A1 (de) Inhalative Arzneimittel enthaltend Corticosteroide, Betamimetika sowie ein neues Anticholinergikum

Legal Events

Date Code Title Description
8141 Disposal/no request for examination